PERCEPTIVE ADVISORS LLC - 26 Sep 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
10%+ Owner
Signature
/s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Issuer symbol
SLNO
Transactions as of
26 Sep 2023
Net transactions value
+$20,111,416
Form type
4
Filing time
28 Sep 2023, 15:45:22 UTC
Previous filing
23 Jun 2023
Next filing
18 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Purchase $43,628 +5,703 +0.26% $7.65 2,213,456 26 Sep 2023 See Footnote F1, F2, F3
transaction SLNO Common Stock Purchase $113,602 +13,687 +0.62% $8.30 2,227,143 26 Sep 2023 See Footnote F1, F2, F4
transaction SLNO Common Stock Purchase $51,589 +5,419 +0.24% $9.52 2,232,562 26 Sep 2023 See Footnote F1, F2, F5
transaction SLNO Common Stock Purchase $418,917 +37,911 +1.7% $11.05 2,270,473 26 Sep 2023 See Footnote F1, F2, F6
transaction SLNO Common Stock Purchase $919,255 +77,837 +3.4% $11.81 2,348,310 26 Sep 2023 See Footnote F1, F2, F7
transaction SLNO Common Stock Purchase $550,040 +42,838 +1.8% $12.84 2,391,148 26 Sep 2023 See Footnote F1, F2, F8
transaction SLNO Common Stock Purchase $424,713 +30,511 +1.3% $13.92 2,421,659 26 Sep 2023 See Footnote F1, F2, F9
transaction SLNO Common Stock Purchase $48,593 +3,326 +0.14% $14.61 2,424,985 26 Sep 2023 See Footnote F1, F2, F10
transaction SLNO Common Stock Purchase $444,304 +27,769 +1.1% $16.00 2,452,754 26 Sep 2023 See Footnote F1, F2, F11
transaction SLNO Common Stock Purchase $1,304,243 +75,477 +3.1% $17.28 2,528,231 26 Sep 2023 See Footnote F1, F2, F12
transaction SLNO Common Stock Purchase $961,084 +52,691 +2.1% $18.24 2,580,922 26 Sep 2023 See Footnote F1, F2, F13
transaction SLNO Common Stock Purchase $1,694,770 +88,685 +3.4% $19.11 2,669,607 26 Sep 2023 See Footnote F1, F2, F14
transaction SLNO Common Stock Purchase $2,363,460 +117,996 +4.4% $20.03 2,787,603 26 Sep 2023 See Footnote F1, F2, F15
transaction SLNO Common Stock Purchase $775,719 +36,939 +1.3% $21.00 2,824,542 26 Sep 2023 See Footnote F1, F2, F16
transaction SLNO Common Stock Purchase $5,000,000 +250,000 +8.9% $20.00 3,074,542 28 Sep 2023 See Footnote F1, F17

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Pre-funded warrants (right to buy) Purchase $4,997,500 +250,000 $19.99 250,000 28 Sep 2023 Common Stock 250,000 $0.0100 See Footnote F1, F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F2 The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported.
F3 These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.87, inclusive.
F4 These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.89, inclusive.
F5 These shares were purchased in multiple transactions at prices ranging from $9.32 to $9.73, inclusive.
F6 These shares were purchased in multiple transactions at prices ranging from $10.39 to $11.38, inclusive.
F7 These shares were purchased in multiple transactions at prices ranging from $11.39 to $12.40, inclusive.
F8 These shares were purchased in multiple transactions at prices ranging from $12.41 to $13.40, inclusive.
F9 These shares were purchased in multiple transactions at prices ranging from $13.42 to $14.41, inclusive.
F10 These shares were purchased in multiple transactions at prices ranging from $14.42 to $15.00, inclusive.
F11 These shares were purchased in multiple transactions at prices ranging from $15.66 to $16.50, inclusive.
F12 These shares were purchased in multiple transactions at prices ranging from $16.70 to $17.695, inclusive.
F13 These shares were purchased in multiple transactions at prices ranging from $17.70 to $18.69, inclusive.
F14 These shares were purchased in multiple transactions at prices ranging from $18.70 to $19.69, inclusive.
F15 These shares were purchased in multiple transactions at prices ranging from $19.70 to $20.69, inclusive.
F16 These shares were purchased in multiple transactions at prices ranging from $20.70 to $21.40, inclusive.
F17 Purchased in the Issuer's registered public offering scheduled to close on October 2, 2023.
F18 Represents pre-funded warrants purchased in the Issuer's private placement scheduled to close on October 2, 2023. The pre-funded warrants may not be exercised if the holder together with its affiliates would beneficially own more than 9.99% of the Issuer's outstanding shares of common stock after giving effect to the exercise.